Comparison of the efficacy of triple versus quadruple therapy on the eradication of Helicobacter pylori and antibiotic resistance

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Digestive Diseases

• Publication date

  2010-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1751-2980.2010.00457.xPMID 20883428
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical analysis of resistance of Hp isolates to five antibiotics

  2009cited by this paper
• Meta‐analysis: high‐dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication

  2008cited by this paper
• Prevalence of Helicobacter pylori Resistance to Antibiotics and its Influence on the Treatment Outcome in China:A Multicenter Clinical Study

  2007cited by this paper
• The Development of Therapeutic and Preventive Vaccines for Gastric Cancer and Helicobacter pylori

  2005cited by this paper
• Meta‐analysis: the efficacy, adverse events, and adherence related to first‐line anti‐Helicobacter pylori quadruple therapies

  2004cited by this paper
• Bismuth-Based Quadruple Therapy Using a Single Capsule of Bismuth Biskalcitrate, Metronidazole, and Tetracycline Given With Omeprazole Versus Omeprazole, Amoxicillin, and Clarithromycin for Eradication of Helicobacter pylori in Duodenal Ulcer Patients: A Prospective, Randomized, Multicenter, North A

  2003cited by this paper
• Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report

  2002cited by this paper
• Prevalence of Helicobacter pylori Resistance to Metronidazole, Clarithromycin, Amoxicillin, Tetracycline, and Furazolidone in Brazil

  2000cited by this paper

• High-dose dual therapy for Helicobacter pylori eradication inducing less impact on the gut microbiota

  2025cites this paper
• Comparative Efficacy of Triple Versus Quadruple Therapy for the Eradication of Helicobacter pylori Infection in Asian Adults—A Systematic Review and Meta‐Analysis

  2025cites this paper
• Efficacy and Safety of 10‐Day Versus 14‐Day Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis

  2025cites this paper
• Vonoprazan-based quadruple therapy is non-inferior to esomeprazole-based quadruple therapy for Helicobacter pylori eradication: A multicenter, double-blind, randomized, phase 3 study

  2025cites this paper
• ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

  2024cites this paper
• Association of long-term use of low-dose aspirin with Helicobacter pylori infection and effect on recurrence rate

  2024influential citation
• Efficacy and safety of 10-day versus 14-day bismuth-containing quadruple therapy for H. pylori eradication: A systematic review and meta-analysis

  2024cites this paper
• Helicobacter pylori antibiotic resistance in different regions of China: A systematic review and meta-analysis

  2024cites this paper
• Comparison of the efficacies of triple, quadruple and sequential antibiotic therapy in eradicating Helicobacter pylori infection: A randomized controlled trial

  2023cites this paper
• Novel Information Regarding the Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

  2023cites this paper
• Treatment of Helicobacter Pylori Infections Using Moxifloxacin-Triple Therapy Compared to Standard Triple and Quadruple Therapies

  2023cites this paper
• Furazolidone-induced pulmonary toxicity in Helicobacter pylori infection: Two case reports

  2023cites this paper
• Primary Antibiotic Resistance of Helicobacter pylori in Different Regions of China: A Systematic Review and Meta-Analysis

  2022cites this paper
• Comparison of high‐dose dual therapy with bismuth‐containing quadruple therapy in Helicobacter pylori‐infected treatment‐naive patients: An open‐label, multicenter, randomized controlled trial

  2022cites this paper
• 2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment

  2022influential citation
• Comparative effectiveness of first-line therapies for eradication of antibiotic-resistant Helicobacter pylori strains: A network meta-analysis

  2022cites this paper
• Multiple Bismuth Quadruple Therapy Containing Tetracyclines Combined with Other Antibiotics and Helicobacter pylori Eradication Therapy

  2022cites this paper
• Efficacy and safety of triple therapy containing berberine hydrochloride, amoxicillin, and rabeprazole in the eradication of Helicobacter pylori

  2022cites this paper
• Efficacy and safety of high-dose esomeprazole–amoxicillin dual therapy for Helicobacter pylori rescue treatment: a multicenter, prospective, randomized, controlled trial

  2022cites this paper
• Standard Triple Therapy as a Remedy for Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

  2022cites this paper
• The effect of previous eradication failure on antibiotic resistance of Helicobacter pylori: A retrospective study over 8 years in Beijing

  2021cites this paper
• The Efficacy and Safety of Regimens for Helicobacter pylori Eradication Treatment in China

  2021cites this paper
• Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: a Network Meta-Analysis.

  2021cites this paper
• Bismuth drugs as antimicrobial agents

  2020cites this paper
• The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta‐analysis

  2020cites this paper
• Analysis of the primary and post-treatment antibiotic resistance of Helico-bacter pylori in Nanjing area.

  2020cites this paper
• Half‐dose clarithromycin‐containing bismuth quadruple therapy is effective and economical in treating Helicobacter pylori infection: A single‐center, open‐label, randomized trial

  2019cites this paper
• Evaluation of diagnostic and treatment strategies for the management of Helicobacter pylori infection

  2019cites this paper
• Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions.

  2018cites this paper
• Eradication of Helicobacter pylori infection with a new bismuth-based quadruple therapy in clinical practice.

  2018cites this paper
• Clarithromycin resistance and female gender affect Helicobacter pylori eradication failure in chronic gastritis

  2018cites this paper
• New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese prospective, randomized, multicentre trial

  2018cites this paper
• Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Tria

  2018cites this paper
• Consensus on the clinical management, screening‐to‐treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale

  2017cites this paper
• Eradication of Helicobacter pylori infection with a new bismuth-based quadruple therapy in clinical practice.

  2017cites this paper
• Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance

  2017influential citation
• Primary Antibiotic Resistance of Helicobacter pylori in China

  2017cites this paper
• Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes

  2017cites this paper
• Berberine containing quadruple therapy for initial Helicobacter pylori eradication

  2017cites this paper
• First-Line Treatment in the Eradication of Helicobacter Pylori: where are we now?

  2017cites this paper
• Dispepsi Şikâyeti ile Başvuran Hastalarda Helikobakter Pilori Pozitifliği Açisindan C-14 Üre Nefes Testi ile Endoskopinin Karşilaştirilmasi Comparison of Endoscopy and C-14 Urea Breath Test in Terms of Helicobacter Pylori Positivity in Patients Admitted with Complaints of Dyspepsia

  2016cites this paper
• A high-throughput multiplex genetic detection system for Helicobacter pylori identification, virulence and resistance analysis.

  2016cites this paper
• Comparison Between Sequential Therapy and Modified Bismuth-Included Quadruple Therapy for Helicobacter pylori Eradication in Chinese Patients

  2016cites this paper
• How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly.

  2015cites this paper
• Review: Clinical Management of Helicobacter pylori Infection in China

  2015cites this paper
• Pharmacological therapy used in the elimination of Helicobacter pylori infection: a review.

  2015cites this paper
• Triple and quadruple eradication therapy for H. pylori in Iraqi patients with peptic ulcer disease a comparative study.

  2015cites this paper
• Comparison of three different regimens against Helicobacter pylori as a first-line treatment: A randomized clinical trial.

  2015cites this paper
• Helicobacter pylori: management in 2013.

  2014cites this paper
• Tetracycline‐ and Furazolidone‐containing Quadruple Regimen as Rescue Treatment for Helicobacter pylori Infection: A Single Center Retrospective Study

  2014cites this paper
• Sequential Therapy vs Quadruple Therapy for Helicobacter pylori Eradication in South West of Iran

  2014cites this paper
• Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance.

  2014cites this paper
• First-line therapy in Helicobacter pylori eradication therapy: experience of a surgical clinic.

  2014influential citation
• Furazolidone-based triple and quadruple eradication therapy for Helicobacter pylori infection.

  2014cites this paper
• Meta-Analysis of Bismuth Quadruple Therapy versus Clarithromycin Triple Therapy for Empiric Primary Treatment of Helicobacter pylori Infection

  2013cites this paper
• Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection

  2013cites this paper
• How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?

  2013cites this paper
• Bismuth-containing quadruple therapy for Helicobacter pylori: lessons from China

  2013cites this paper
• Prevention of Gastric Ulcers

  2011cites this paper
• A new paradigm for clinical trials in antibiotherapy?

  2011cites this paper
• Review of pantoprazole in pediatrics

  2011cites this paper
• Drug Evaluation Review of pantoprazole in pediatrics

  2011cites this paper